STAT+: FDA spells out 2027 AI guidance plans
Reported by STAT News · all stories from statnews.com
Editorial digest
The Food and Drug Administration has outlined its intentions for providing guidance regarding artificial intelligence by the year 2027. This information offers insight into upcoming regulatory developments for health technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/7/2026
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
Utah's healthcare artificial intelligence trials may conflict with federal regulatory bodies.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Trusted health newsroom10/14/2026
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Industry representatives are working to influence state-level medical artificial intelligence rules.
- Trusted health newsroom10/15/2026
STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future
Industry experts are working to influence the development of regulatory frameworks for artificial intelligence innovation zones.
- Trusted health newsroom10/15/2026
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
An opinion piece describes difficulties in opting out of health data sharing through MyChart.